KYMR vs VNO · rev $99.4M vs rev $921.3M
Kymera Therapeutics Inc (KYMR) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
VNO (VNO) common stock.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
KYMR currently screens at market cap $7.39B. VNO currently screens at market cap $0.
Not investment advice. Open the KYMR and VNO stock pages for the full models.
Not investment advice.